+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Arrest Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4803336
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • GE Healthcare
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer Inc.
  • MORE
The report on the global cardiac arrest treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global cardiac arrest treatment market to grow with a CAGR of 4.8% over the forecast period from 2019-2025. The study on cardiac arrest treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on cardiac arrest treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cardiac arrest treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cardiac arrest treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Growing incidence of heart related problem around the globe
  • Changing consumption and living habit among the young and middle class consumers
2) Restraints
  • Lack of availability of the healthcare professionals in the developing countries
3) Opportunities
  • Growing demand of heart related medical treatment services in the developing country
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global cardiac arrest treatment market is segmented on the basis of treatment, and sales channel.

The Global Cardiac Arrest Treatment Market by Treatment
  • Drug
o Corticosteroids
o Fibrinolytic Drugs
o Beta Blockers
o Anticholinergic Drugs
o Anti-arrhythmic Drugs
o Vasopressors
o Other treatments (Crystalloids, Sodium Bicarbonate, Colloids)
  • Medical Devices
o Cardiac Resynchronization Therapy
o Defibrillators
o Other medical devices

The Global Cardiac Arrest Treatment Market by Sales Channel
  • Hospitals
  • Independent Pharmacies
  • Other sales channel
Company Profiles
The companies covered in the report include
  • Boston Scientific Corporation
  • GE Healthcare
  • Abbott Laboratories
  • Bristol-Myers Squibb Company
  • Novartis International AG
  • Johnson & Johnson
  • Pfizer Inc.
  • Amgen Inc.
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the cardiac arrest treatment market.
2. Complete coverage of all the segments in the cardiac arrest treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global cardiac arrest treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • GE Healthcare
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer Inc.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Cardiac Arrest Treatment Market Highlights
2.2. Cardiac Arrest Treatment Market Projection
2.3. Cardiac Arrest Treatment Market Regional Highlights

3. Global Cardiac Arrest Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Treatment
3.4.2. Growth Matrix Analysis by Sales Channel
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Cardiac Arrest Treatment Market

4. Cardiac Arrest Treatment Market Macro Indicator Analysis

5. Global Cardiac Arrest Treatment Market by Treatment
5.1. Drug
5.1.1. Corticosteroids
5.1.2. Fibrinolytic Drugs
5.1.3. Beta Blockers
5.1.4. Anticholinergic Drugs
5.1.5. Anti-arrhythmic Drugs
5.1.6. Vasopressors
5.1.7. Other treatments (Crystalloids, Sodium Bicarbonate, Colloids)
5.2. Medical Devices
5.2.1. Cardiac Resynchronization Therapy
5.2.2. Defibrillators
5.2.3. Others

6. Global Cardiac Arrest Treatment Market by Sales Channel
6.1. Hospitals
6.2. Independent Pharmacies
6.3. Other sales channel

7. Global Cardiac Arrest Treatment Market by Region 2019-2025
7.1. North America
7.1.1. North America Cardiac Arrest Treatment Market by Treatment
7.1.2. North America Cardiac Arrest Treatment Market by Sales Channel
7.1.3. North America Cardiac Arrest Treatment Market by Country
7.2. Europe
7.2.1. Europe Cardiac Arrest Treatment Market by Treatment
7.2.2. Europe Cardiac Arrest Treatment Market by Sales Channel
7.2.3. Europe Cardiac Arrest Treatment Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Cardiac Arrest Treatment Market by Treatment
7.3.2. Asia-Pacific Cardiac Arrest Treatment Market by Sales Channel
7.3.3. Asia-Pacific Cardiac Arrest Treatment Market by Country
7.4. RoW
7.4.1. RoW Cardiac Arrest Treatment Market by Treatment
7.4.2. RoW Cardiac Arrest Treatment Market by Sales Channel
7.4.3. RoW Cardiac Arrest Treatment Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Cardiac Arrest Treatment Market
8.2. Companies Profiles
8.2.1. Boston Scientific Corporation
8.2.2. GE Healthcare
8.2.3. Abbott Laboratories
8.2.4. Bristol-Myers Squibb Company
8.2.5. Novartis International AG
8.2.6. Johnson & Johnson
8.2.7. Pfizer Inc.
8.2.8. Amgen Inc.

9. Appendix
9.1. Primary Research Findings and Questionnaire

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Boston Scientific Corporation
  • GE Healthcare
  • Abbott Laboratories
  • Bristol-Myers Squibb Company
  • Novartis International AG
  • Johnson & Johnson
  • Pfizer Inc.
  • Amgen Inc.
Note: Product cover images may vary from those shown
Adroll
adroll